Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
Kura Oncology, Inc.
7 Hills Pharma, LLC
KaliVir Immunotherapeutics
Bristol-Myers Squibb
Pfizer
Actuate Therapeutics Inc.
Arcus Biosciences, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Arcus Biosciences, Inc.
Neomorph, Inc
AstraZeneca
Xencor, Inc.
Nuvectis Pharma, Inc.
Psyence Australia Pty Ltd
Pfizer
Pfizer
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
Merck Sharp & Dohme LLC
Takeda
Adela, Inc
HiberCell, Inc.
Second Life Therapeutics
Elephas
Novartis
Elephas
HistoSonics, Inc.
Merck Sharp & Dohme LLC
Lantheus Medical Imaging
Degron Therapeutics Co.
HistoSonics, Inc.
Medtronic - MITG
Sichuan Baili Pharmaceutical Co., Ltd.
AstraZeneca
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc.
Coherus Oncology, Inc.
Massive Bio, Inc.
Arsenal Biosciences, Inc.
Hutom Corp
A2 Biotherapeutics Inc.
Sensei Biotherapeutics, Inc.
Delfi Diagnostics Inc.
Pfizer
Ourotech, Inc.
A2 Biotherapeutics Inc.
Bristol-Myers Squibb
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Genentech, Inc.